Skip to main content

Table 4 Time (in hours post first dose) of rescue and recurrence treatment, second dose intention-to-treat population

From: Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN)

 

Placebo

Lasmiditan 50 mg

Lasmiditan 100 mg

Lasmiditan 200 mg

RESCUE, n

606

245

388

310

- 25th percentile

2.0

2.0

2.0

2.0

- Median

2.0

2.0

2.0

2.0

- 75th percentile

2.0

2.0

2.0

2.6

RECURRENCE, n

21

13

35

28

- 25th percentile

4.0

7.6

4.5

8.0

- Median

7.0

11.3

9.5

19.3

- 75th percentile

11.5

18.4

18.8

22.1

  1. Abbreviation: n number of patients
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us